戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  disorder distinct from chronic inflammatory demyelinating polyneuropathy.
2 lain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy.
3 anti-myelin-associated glycoprotein antibody demyelinating polyneuropathy.
4 llain-Barre syndrome or chronic inflammatory demyelinating polyneuropathy.
5 opathy as distinct from chronic inflammatory demyelinating polyneuropathy.
6  within the spectrum of chronic inflammatory demyelinating polyneuropathy.
7 tment for patients with chronic inflammatory demyelinating polyneuropathy.
8 in patients with active chronic inflammatory demyelinating polyneuropathy.
9 rse myelitis, and 1 had chronic inflammatory demyelinating polyneuropathy.
10 %) with newly diagnosed chronic inflammatory demyelinating polyneuropathy.
11 ssociation between CD and acute inflammatory demyelinating polyneuropathy (0.8; 0.3-2.1; P = .68).
12 study of rituximab in patients with anti-MAG demyelinating polyneuropathy (A-MAG-DP).
13     In chronic cases of chronic inflammatory demyelinating polyneuropathy, a concomitant axonal loss
14 ropathy and variants of chronic inflammatory demyelinating polyneuropathy, account for a proportion o
15 pathologic criteria, with acute inflammatory demyelinating polyneuropathy (AIDP) and acute motor axon
16 hina occurs in two forms: acute inflammatory demyelinating polyneuropathy (AIDP) and acute motor axon
17 ts in early stages of the acute inflammatory demyelinating polyneuropathy (AIDP) pattern of Guillain-
18 nd less frequently in the acute inflammatory demyelinating polyneuropathy (AIDP) type of GBS or in ce
19                        In acute inflammatory demyelinating polyneuropathy (AIDP), the attack appears
20 ived from patients with chronic inflammatory demyelinating polyneuropathy, an autoimmune disease of t
21                            The evaluation of demyelinating polyneuropathies and the data for treatmen
22 tion indicated for a patient presenting with demyelinating polyneuropathy and concurrent papilledema.
23 ren's syndrome, sensory chronic inflammatory demyelinating polyneuropathy and paraneoplastic neuropat
24 focal motor neuropathy, chronic inflammatory demyelinating polyneuropathy, and dermatomyositis.
25 uillain-Barre syndrome, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuro
26 enous immunoglobulin in chronic inflammatory demyelinating polyneuropathy are warranted.
27                         Eleven patients with demyelinating polyneuropathy associated with monoclonal
28 a multifocal variant of chronic inflammatory demyelinating polyneuropathy but that multifocal motor n
29 inclusion-body myositis, paraproteinemic IgM demyelinating polyneuropathy, certain intractable childh
30 The association between chronic inflammatory demyelinating polyneuropathy (CIDP) and diabetes is unce
31 opathies, which include chronic inflammatory demyelinating polyneuropathy (CIDP) and Guillain Barre s
32 arre syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP) are conditions that
33 ar clinical features of chronic inflammatory demyelinating polyneuropathy (CIDP) except 'motor neurop
34                         Chronic inflammatory demyelinating polyneuropathy (CIDP) has occasionally bee
35 increased prevalence of chronic inflammatory demyelinating polyneuropathy (CIDP) in patients with dia
36                         Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune-mediate
37                         Chronic inflammatory demyelinating polyneuropathy (CIDP) is rare but the most
38 e Society (EAN/PNS) for chronic inflammatory demyelinating polyneuropathy (CIDP) is unknown.
39 thirds of patients with chronic inflammatory demyelinating polyneuropathy (CIDP) need long-term intra
40  and nine patients with chronic inflammatory demyelinating polyneuropathy (CIDP) were compared with 1
41 opsies of patients with chronic inflammatory demyelinating polyneuropathy (CIDP), CIDP associated wit
42 of nerve hypertrophy in chronic inflammatory demyelinating polyneuropathy (CIDP), magnetic resonance
43 n reported as mimicking chronic inflammatory demyelinating polyneuropathy (CIDP).
44 mbles the human disease chronic inflammatory demyelinating polyneuropathy (CIDP).
45 s to the human disease, chronic inflammatory demyelinating polyneuropathy (CIDP).
46  in the pathogenesis of chronic inflammatory demyelinating polyneuropathy (CIDP).
47 lain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy (CIDP).
48 ribed for patients with chronic inflammatory demyelinating polyneuropathy (CIDP).
49 autoimmunity resembling chronic inflammatory demyelinating polyneuropathy develops spontaneously in N
50 e (GBS), especially the classic inflammatory demyelinating polyneuropathy form, seems to involve lymp
51 lain Barre Syndrome and chronic inflammatory demyelinating polyneuropathy), immune cells are proinfla
52 ence of CMT disease and chronic inflammatory demyelinating polyneuropathy indicate that the associati
53                         Chronic inflammatory demyelinating polyneuropathy is a debilitating autoimmun
54            CMT4C is typically a sensorimotor demyelinating polyneuropathy, marked by early onset spin
55 uillain-Barre syndrome, chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropath
56 uillain-Barre syndrome, chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropath
57 uillain-Barre Syndrome, chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropath
58         The Progress in Chronic Inflammatory Demyelinating polyneuropathy (ProCID) study was a prospe
59 e immunopathogenesis of chronic inflammatory demyelinating polyneuropathy remain still fragmentary an
60                         Chronic inflammatory demyelinating polyneuropathy results from autoimmune des
61                         An acute or subacute demyelinating polyneuropathy should be considered a pote
62 past medical history of chronic inflammatory demyelinating polyneuropathy, Sjogren's syndrome, and sy
63  were consistent with the acute inflammatory demyelinating polyneuropathy subtype of the Guillain-Bar
64  it can be mistaken for chronic inflammatory demyelinating polyneuropathy; this misdiagnosis may lead
65 oglobulin treatment for chronic inflammatory demyelinating polyneuropathy usually starts with a 2.0 g